HERVs Targeted Immunotherapy Funding
HERVolution Therapeutics raises $11.70M for innovative immunotherapies targeting HERVs, linked to cancer and aging-related diseases.
Learn more
#HERVolution $11.70M #Immunotherapy#Cancer#Aging#MetabolicDiseases#Funding